Industry: Service & Software
Published Date: 2025-06-03
Pages: 82 Pages
Report ld: 4749989
Request Sample
Customized Report
Oncology Clinical Management Technology Market Size(US$)

CAGR 2025-2031
18.5%
Market Size,2031
USD 26,370
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Oncology Clinical Management Technology was valued at US$ 9244 million in the year 2024 and is projected to reach a revised size of US$ 26370 million by 2031, growing at a CAGR of 18.5% during the forecast period.
Oncology Clinical Management Technology refers to the integrated digital systems, platforms, and tools specifically designed to support the comprehensive care of cancer patients. These technologies facilitate the diagnosis, treatment planning, monitoring, and long-term management of oncology cases, ensuring improved clinical outcomes, workflow efficiency, and personalized patient care.
North American market for Oncology Clinical Management Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oncology Clinical Management Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oncology Clinical Management Technology in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oncology Clinical Management Technology include McKesson, Tempus, IQVIA, Epic Systems, Flatiron Health, Cerner, Veeva Systems, Carevive, Jasper Health, Zhejiang Haixinzhihui Technology Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oncology Clinical Management Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Clinical Management Technology.
The Oncology Clinical Management Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Clinical Management Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Clinical Management Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Clinical Management Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Clinical Management Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oncology Information System (OIS)
1.2.3 Clinical Decision Support System (CDSS)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Clinical Management Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Tumor Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Clinical Management Technology Market Perspective (2020-2031)
2.2 Global Oncology Clinical Management Technology Growth Trends by Region
2.2.1 Global Oncology Clinical Management Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Clinical Management Technology Historic Market Size by Region (2020-2025)
2.2.3 Oncology Clinical Management Technology Forecasted Market Size by Region (2026-2031)
2.3 Oncology Clinical Management Technology Market Dynamics
2.3.1 Oncology Clinical Management Technology Industry Trends
2.3.2 Oncology Clinical Management Technology Market Drivers
2.3.3 Oncology Clinical Management Technology Market Challenges
2.3.4 Oncology Clinical Management Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Clinical Management Technology Players by Revenue
3.1.1 Global Top Oncology Clinical Management Technology Players by Revenue (2020-2025)
3.1.2 Global Oncology Clinical Management Technology Revenue Market Share by Players (2020-2025)
3.2 Global Top Oncology Clinical Management Technology Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Clinical Management Technology Revenue
3.4 Global Oncology Clinical Management Technology Market Concentration Ratio
3.4.1 Global Oncology Clinical Management Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Management Technology Revenue in 2024
3.5 Global Key Players of Oncology Clinical Management Technology Head office and Area Served
3.6 Global Key Players of Oncology Clinical Management Technology, Product and Application
3.7 Global Key Players of Oncology Clinical Management Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Clinical Management Technology Breakdown Data by Type
4.1 Global Oncology Clinical Management Technology Historic Market Size by Type (2020-2025)
4.2 Global Oncology Clinical Management Technology Forecasted Market Size by Type (2026-2031)
5 Oncology Clinical Management Technology Breakdown Data by Application
5.1 Global Oncology Clinical Management Technology Historic Market Size by Application (2020-2025)
5.2 Global Oncology Clinical Management Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Clinical Management Technology Market Size (2020-2031)
6.2 North America Oncology Clinical Management Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Clinical Management Technology Market Size by Country (2020-2025)
6.4 North America Oncology Clinical Management Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Clinical Management Technology Market Size (2020-2031)
7.2 Europe Oncology Clinical Management Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Clinical Management Technology Market Size by Country (2020-2025)
7.4 Europe Oncology Clinical Management Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Clinical Management Technology Market Size (2020-2031)
8.2 Asia-Pacific Oncology Clinical Management Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Clinical Management Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Clinical Management Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Clinical Management Technology Market Size (2020-2031)
9.2 Latin America Oncology Clinical Management Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Clinical Management Technology Market Size by Country (2020-2025)
9.4 Latin America Oncology Clinical Management Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Clinical Management Technology Market Size (2020-2031)
10.2 Middle East & Africa Oncology Clinical Management Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Clinical Management Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Clinical Management Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 McKesson
11.1.1 McKesson Company Details
11.1.2 McKesson Business Overview
11.1.3 McKesson Oncology Clinical Management Technology Introduction
11.1.4 McKesson Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.1.5 McKesson Recent Development
11.2 Tempus
11.2.1 Tempus Company Details
11.2.2 Tempus Business Overview
11.2.3 Tempus Oncology Clinical Management Technology Introduction
11.2.4 Tempus Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.2.5 Tempus Recent Development
11.3 IQVIA
11.3.1 IQVIA Company Details
11.3.2 IQVIA Business Overview
11.3.3 IQVIA Oncology Clinical Management Technology Introduction
11.3.4 IQVIA Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.3.5 IQVIA Recent Development
11.4 Epic Systems
11.4.1 Epic Systems Company Details
11.4.2 Epic Systems Business Overview
11.4.3 Epic Systems Oncology Clinical Management Technology Introduction
11.4.4 Epic Systems Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.4.5 Epic Systems Recent Development
11.5 Flatiron Health
11.5.1 Flatiron Health Company Details
11.5.2 Flatiron Health Business Overview
11.5.3 Flatiron Health Oncology Clinical Management Technology Introduction
11.5.4 Flatiron Health Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.5.5 Flatiron Health Recent Development
11.6 Cerner
11.6.1 Cerner Company Details
11.6.2 Cerner Business Overview
11.6.3 Cerner Oncology Clinical Management Technology Introduction
11.6.4 Cerner Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.6.5 Cerner Recent Development
11.7 Veeva Systems
11.7.1 Veeva Systems Company Details
11.7.2 Veeva Systems Business Overview
11.7.3 Veeva Systems Oncology Clinical Management Technology Introduction
11.7.4 Veeva Systems Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.7.5 Veeva Systems Recent Development
11.8 Carevive
11.8.1 Carevive Company Details
11.8.2 Carevive Business Overview
11.8.3 Carevive Oncology Clinical Management Technology Introduction
11.8.4 Carevive Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.8.5 Carevive Recent Development
11.9 Jasper Health
11.9.1 Jasper Health Company Details
11.9.2 Jasper Health Business Overview
11.9.3 Jasper Health Oncology Clinical Management Technology Introduction
11.9.4 Jasper Health Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.9.5 Jasper Health Recent Development
11.10 Zhejiang Haixinzhihui Technology Co., Ltd.
11.10.1 Zhejiang Haixinzhihui Technology Co., Ltd. Company Details
11.10.2 Zhejiang Haixinzhihui Technology Co., Ltd. Business Overview
11.10.3 Zhejiang Haixinzhihui Technology Co., Ltd. Oncology Clinical Management Technology Introduction
11.10.4 Zhejiang Haixinzhihui Technology Co., Ltd. Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.10.5 Zhejiang Haixinzhihui Technology Co., Ltd. Recent Development
11.11 PAREXEL
11.11.1 PAREXEL Company Details
11.11.2 PAREXEL Business Overview
11.11.3 PAREXEL Oncology Clinical Management Technology Introduction
11.11.4 PAREXEL Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.11.5 PAREXEL Recent Development
11.12 Bioclinica
11.12.1 Bioclinica Company Details
11.12.2 Bioclinica Business Overview
11.12.3 Bioclinica Oncology Clinical Management Technology Introduction
11.12.4 Bioclinica Revenue in Oncology Clinical Management Technology Business (2020-2025)
11.12.5 Bioclinica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Oncology Clinical Management Technology market is projected to grow from US$ 9517 million in 2025 to US$ 30760 million by 2032, at a CAGR of 18.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 145
USD 4900.00
(Single User License)
The global Oncology Clinical Management Technology market size was US$ 9517 million in 2025 and is forecast to reach a readjusted size of US$ 30760 million by 2032 with a CAGR of 18.5% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 95
USD 4250.00
(Single User License)
The global market for Oncology Clinical Management Technology was estimated to be worth US$ 9517 million in 2025 and is projected to reach US$ 30760 million, growing at a CAGR of 18.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 110
USD 3950.00
(Single User License)
The global Oncology Clinical Management Technology market was valued at US$ 9517 million in 2025 and is anticipated to reach US$ 30760 million by 2032, at a CAGR of 18.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 113
USD 2900.00
(Single User License)
The global Oncology Clinical Management Technology market is projected to grow from US$ 9517 million in 2025 to US$ 26370 million by 2031, at a Compound Annual Growth Rate (CAGR) of 18.5% during the forecast period.
Published Date: 2025-06-03
Pages: 131
USD 4900.00
(Single User License)
The global Oncology Clinical Management Technology market size was US$ 9244 million in 2024 and is forecast to a readjusted size of US$ 26370 million by 2031 with a CAGR of 18.5% during the forecast period 2025-2031.
Published Date: 2025-06-03
Pages: 96
USD 4250.00
(Single User License)
The global market for Oncology Clinical Management Technology was estimated to be worth US$ 9244 million in 2024 and is forecast to a readjusted size of US$ 26370 million by 2031 with a CAGR of 18.5% during the forecast period 2025-2031.
Published Date: 2025-06-03
Pages: 116
USD 3950.00
(Single User License)
The global Oncology Clinical Management Technology market is projected to grow from US$ 9517 million in 2025 to US$ 30760 million by 2032, at a CAGR of 18.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 145
The global Oncology Clinical Management Technology market size was US$ 9517 million in 2025 and is forecast to reach a readjusted size of US$ 30760 million by 2032 with a CAGR of 18.5% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 95
The global market for Oncology Clinical Management Technology was estimated to be worth US$ 9517 million in 2025 and is projected to reach US$ 30760 million, growing at a CAGR of 18.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 110
The global Oncology Clinical Management Technology market was valued at US$ 9517 million in 2025 and is anticipated to reach US$ 30760 million by 2032, at a CAGR of 18.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 113
The global Oncology Clinical Management Technology market is projected to grow from US$ 9517 million in 2025 to US$ 26370 million by 2031, at a Compound Annual Growth Rate (CAGR) of 18.5% during the forecast period.
Published: 2025-06-03
Pages: 131
The global Oncology Clinical Management Technology market size was US$ 9244 million in 2024 and is forecast to a readjusted size of US$ 26370 million by 2031 with a CAGR of 18.5% during the forecast period 2025-2031.
Published: 2025-06-03
Pages: 96
The global market for Oncology Clinical Management Technology was estimated to be worth US$ 9244 million in 2024 and is forecast to a readjusted size of US$ 26370 million by 2031 with a CAGR of 18.5% during the forecast period 2025-2031.
Published: 2025-06-03
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now